Why Goldman Sachs has added Edwards Lifesciences to its June US Conviction List
Latest selections add five and cut four stocksMedical kit maker seen as an attractive option, Goldman saysReturns on capital and equity at 17.8% and 21.6%On Monday (3 Jun), analysts at investment bank Goldman Sachs did their monthly...
04 June 2024